Brief: Moleculin Biotech Announced 1-For-15 Reverse Stock Split
March 20 (Reuters) - Moleculin Biotech Inc MBRX.O :
* MOLECULIN BIOTECH INC - ANNOUNCED A 1-FOR-15 REVERSE STOCK
SPLIT
OF ITS COMMON STOCK
* MOLECULIN ANNOUNCES REVERSE STOCK SPLIT
* MOLECULIN BIOTECH : REVERSE STOCK SPLIT IS PART OF CO'S
PLAN TO
REGAIN COMPLIANCE WITH MINIMUM BID PRICE REQUIREMENT FOR
CONTINUED LISTING ON NASDAQ
Source text for Eikon: ID:nPn5DqkPra
Further company coverage: MBRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Moleculin Biotech
See all newsMoleculin Biotech Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Moleculin Secures Australian Patent For Annamycin Formulation Technology
Moleculin Biotech Inc expected to post a loss of $8.87 a share - Earnings Preview
Brief: Moleculin Biotech Completes Dosing In Part A Of Miracle Trial Data Readout On Track For Q1 2027
NASDAQ RESUMED AT 09:00 AM